Last reviewed · How we verify

NCT05674188

AR vs In Person Simulation for Medical Workplace Training

Completed NA Last updated 2 January 2024
What this trial tests

NA trial testing Augmented Reality Headset in Augmented Reality in 111 participants. Completed in 22 March 2023.

Timeline
20 March 2023
Primary endpoint
22 March 2023
22 March 2023

Quick facts

Lead sponsorStanford University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment111
Start date20 March 2023
Primary completion22 March 2023
Estimated completion22 March 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Stanford University

Who can join

18 and older, any sex, with Augmented Reality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the physiologic and emotional effects of an augmented reality (AR) simulation versus an in-person simulation. This is a single institution, non-inferiority, randomized controlled trial. The target enrollment will be 100 participants in each group for a total of 200 participants. One group will wear an AR headset and participate in an AR medical crisis scenario and the other group will participate in the same scenario with a traditional, mannequin based in situ simulation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Physiologic Effect of Augmented Reality Simulation Versus Traditional Simulation: A Noninferiority, Randomized Controlled Trial.
    Rama A, Rojas-Pino MS, Wang EY, Rodriguez ST, et al · · 2025 · PMID 40207076 · DOI 10.46374/volxxvii_issue1_rama

Verify or expand the search:

Other trials of Augmented Reality Headset

Trials testing the same drug.

Other recruiting trials for Augmented Reality

Currently open trials in the same condition.

Other Stanford University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05674188.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing